CAPRICOR THERAPEUTICS, INC.

Insiders Capricor Therapeutics, Inc.

Equities

CAPR

US14070B3096

Delayed Nasdaq Other stock markets 03:56:27 2024-05-09 pm EDT			5-day change	1st Jan Change
5.4 ^USD	+0.56%		+3.05%	+10.43%

Apr. 29	Transcript : Capricor Therapeutics, Inc. - Special Call
Apr. 24	Capricor Therapeutics Gets Another Type-B Meeting With FDA for Duchenne Muscular Dystrophy Investigational Drug	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Capricor Therapeutics, Inc. Appoints Michael Kelliher to Its Board of Directors	23-09-06	CI
Capricor Therapeutics Announces the Appointment of Philip J. Gotwals to Its Board of Directors	23-07-24	CI
Capricor Therapeutics Announces Appointment of Philip J. Gotwals to Its Board of Directors	23-07-24	CI
Capricor Therapeutics, Inc Announces Board Changes	23-07-13	CI
Insider Sell: Capricor Therapeutics	23-04-27	MT
Capricor Therapeutics Appoints Xavier Avat as Chief Business Officer	22-05-25	CI
Capricor Therapeutics Appoints Karimah Es Sabar to its Board of Directors	21-07-27	CI
Deborah Ascheim Resigns as Chief Medical Officer of Capricor Therapeutics	18-11-02	CI
Capricor Therapeutics, Inc. Appoints Anthony Bergmann, as Chief Financial Officer, Effective January 1, 2018	17-12-22	CI
Gregory W. Schafer Not Stand for Re-Election as Member of the Board of Directors of Capricor Therapeutics, Inc	16-04-15	CI
Capricor Therapeutics Appoints Leland J. Gershell as Chief Financial Officer	16-02-23	CI
Capricor Therapeutics Appoints Deborah Ascheim as Chief Medical Officer	15-08-04	CI
Capricor Therapeutics, Inc. Announces Resignation of Andrew Hamer as Vice President of Medical Affairs, Effective on or About July 30, 2015	15-07-09	CI
Capricor Therapeutics Appoints Houman Hemmati as Vice President of Medical and Clinical Development for New Therapies	15-06-17	CI
Capricor Therapeutics, Inc. Appoints Thomas Copmann as Vice President of Regulatory Affairs and Drug Development	15-02-27	CI
Capricor Therapeutics, Inc. Announces Termination of Employment of Anthony Davies as Chief Technology Officer	14-01-24	CI
Linda Marbanto to Serve as Chief Executive Officer of Capricor Therapeutics, Inc	13-07-08	CI
Capricor, Inc. Appoints Anthony Davies, Ph.D. as Chief Technology Officer	13-03-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW